ECM
CLVS

Element Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Element Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-85,069
Closed -$4.49M – 1057
2018
Q1 		$4.49M Sell
85,069
-82,580
-49% -$4.82M 0.11% 121
2017
Q4 		$11.4M Buy
+167,649
New +$11.7M 0.23% 93

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Element Capital Management's CLVS Position: Q2 2018 in Review

Element Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 85,069 shares — an estimated $4.49M sold.

Element Capital Management first reported a position in CLVS in Q4 2017 and held it in 2 quarters. The position peaked at $11.4M in Q4 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • Element Capital Management reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 85,069 Clovis Oncology, Inc. shares in Q2 2018, an estimated $4.49M.
  • Element Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2017 and held it in 2 quarters.
  • Element Capital Management's Clovis Oncology, Inc. position peaked at $11.4M in Q4 2017.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.